Heart Disease Trial, Recruiting NCT04576130 Sponsor: Rigshospitalet, Denmark Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT04576130
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have coronary artery disease (narrowed heart arteries) and experienced a cardiac arrest caused by a dangerous abnormal heart rhythm, and who had a procedure to open or bypass the blocked arteries before having a defibrillator device (ICD) implanted.
  • People aged 18 or older.
  • People whose heart pumping strength (measured as "ejection fraction") was above 35% at the time they left the hospital, based on the most recent heart function test used to guide their current treatment.

Who may not be able to join:

  • People whose cardiac arrest was caused by something other than blocked heart arteries, such as an inherited heart rhythm condition or a heart muscle disease unrelated to blocked arteries.
  • People who had open-heart bypass surgery (CABG) within the 3 months before their hospital admission for the cardiac arrest.
  • People with a life expectancy of less than one year, or who have serious lasting brain or neurological damage.
  • People who are unable or unwilling to provide their consent to participate in the trial.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Reza Jabbari, MD, PhD, Rigshospitalet, Denmark

Phone: +4535455380

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 October 2020
Est. completion
1 October 2032

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

All-cause mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov